Immunization with excreted/secreted proteins in AS/n mice activating cellular and humoral response against Toxoplasma gondii infection

Acta Tropica

Volumn 124, Issue 3, 2012, Pages 203-209

  Costa Silva, Thaís Alves ^a   Borges, Monamaris Marques ^b   Galhardo, Cynthia Soares ^b   Pereira Chioccola, Vera Lucia ^a  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

Author keywords

Cellular response; Excreted secreted antigens; Humoral response; Toxoplasma gondii

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 4; PARASITE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN; IMMUNE RESPONSE; IMMUNIZATION; PARASITE; PROTEIN; PROTOZOAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EXPERIMENTAL MOUSE; FEMALE; HOST PARASITE INTERACTION; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOSTIMULATION; INFLAMMATION; MORTALITY; MOUSE; NONHUMAN; OPSONIZATION; PARASITEMIA; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; TACHYZOITE; TH1 CELL; TH2 CELL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; LEUKOCYTES, MONONUCLEAR; MICE; PARASITE LOAD; PARASITEMIA; PROTOZOAN VACCINES; REAL-TIME POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; TOXOPLASMOSIS, ANIMAL; VACCINATION;

MUS; TOXOPLASMA GONDII;

EID: 84866999786     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2012.08.013     Document Type: Article

References (50)

1. Anderson C.F., Oukka M., Kuchroo V.J., Sacks D. CD4(+) CD25(-) Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. Journal of Experimental Medicine 2007, 19:285-297.
2. Araújo P.R., Ferreira A.W. High diagnostic efficiency of IgM-ELISA with the use of multiple antigen peptides (MAP1) from T. gondii ESA (SAG-1, GRA-1 and GRA-7) in acute toxoplasmosis. Revista do Instituto de Medicina Tropical de Sao Paulo 2010, 52:63-68.
3. Bojar I., Szymańska J. Environmental exposure of pregnant women to infection with Toxoplasma gondii - state of the art. Annals of Agriculture and Environmental Medicine 2010, 17:209-214.
4. Brandão G.P., Melo M.N., Gazzinelli R.T., Caetano B.C., Ferreira A.M., Silva L.A., Vitor R.W. Experimental reinfection of BALB/c mice with different recombinant type I/III strains of Toxoplasma gondii: involvement of IFN-gamma and IL-10. Memorias do Instituto Oswaldo Cruz 2009, 104:241-245.
5. Brinkmann V., Geiger T., Alkan S., Heusser C.H. Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. Journal of Experimental Medicine 1993, 178:1655-1663.
6. Buxton D., Innes E.A. A commercial vaccine for ovine toxoplasmosis. Parasitology 1995, 110:11-16.
7. Buxton D. Protozoan infections (Toxoplasma gondii, Neospora caninum and Sarcocystis spp.) in sheep and goats: recent advances. Veterinary Research 1998, 29:289-310.
8. Carruthers V.B. Host cell invasion by the opportunistic pathogen Toxoplasma gondii. Acta Tropica 2002, 81:111-122.
9. Castagnini M., Bernazzali S., Ginanneschi C., Marchi B., Maccherini M., Sioulpas C., Tanganelli P. Fatal disseminated toxoplasmosis in a cardiac transplantation with seropositive match for Toxoplasma: should prophylaxis be extended?. Transplant Immunology 2007, 18:193-197.
10. Cérède O., Dubremetz J.F., Soête M., Deslée D., Vial H., Bout D., Lebrun M. Synergistic role of micronemal proteins in Toxoplasma gondii virulence. Journal of Experimental Medicine 2005, 201:453-463.
11. Cesbron-Delauw M.F., Capron A. Excreted-secreted antigens of Toxoplasma gondii: their origin and role in the host-parasite interaction. Research in Immunology 1993, 144:41-44.
12. Costa-Silva T.A., Meira C.S., Ferreira I.M., Hiramoto R.M., Pereira-Chioccola V.L. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii. Experimental Parasitology 2008, 120:227-234.
13. Costa-Silva T.A., Meira C.S., Frazzatti-Gallina N., Pereira-Chioccola V.L. Toxoplasma gondii antigens: recovery analysis of tachyzoites cultivated in Vero cell maintained in serum free medium. Experimental Parasitology 2012, 130:463-469.
14. Denkers E.Y., Gazzinelli R.T. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clinical Microbiology Reviews 1998, 11:569-588.
15. Denkers E.Y. From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii. FEMS Immunology and Medical Microbiology 2003, 39:193-203.
16. Dollfus H., Dureau P., Hennequin C., Uteza Y., Bron A., Dufier J.L. Congenital Toxoplasma chorioretinitis transmitted by preconceptionally immune women. British Journal of Ophthalmology 1998, 82:1444-1445.
17. Dubey J.P. Advances in the life cycle of Toxoplasma gondii. International Journal of Parasitology 1998, 28:1019-1024.
18. Dubey J.P. The history of Toxoplasma gondii - the first 100 years. Journal of Eukaryotic Microbiology 2008, 55:467-475.
19. Dziadek B., Gatkowska J., Brzostek A., Dziadek J., Dzitko K., Dlugonska H. Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis. Experimental Parasitology 2009, 123:81-89.
20. Elbez-Rubinstein A., Ajzenberg D., Dardé M.L., Cohen R., Dumètre A., Year H., Gondon E., Janaud J.C., Thulliez P. Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection, and review. Journal of Infectious Diseases 2009, 199:280-285.
21. Elmore S.A., Jones J.L., Conrad P.A., Patton S., Lindsay D.S., Dubey J.P. Toxoplasma gondii: epidemiology feline clinical aspects, and prevention. Trends in Parasitology 2010, 26:190-196.
22. Filisetti D., Candolfi E. Immune response to Toxoplasma gondii. Annali dell Istituto Superiore di Sanita 2004, 40:71-80.
23. Gazzinelli R., Xu Y., Hieny S., Cheever A., Sher A. Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. Journal of Immunology 1992, 149:175-180.
24. Gazzinelli R.T., Wysocka M., Hieny S., Scharton-Kersten T., Cheever A., Kühn R., Müller W., Trinchieri G., Sher A. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. Journal of Immunology 1996, 157:798-805.
25. Hill D., Dubey J.P. Toxoplasma gondii: transmission diagnosis and prevention. Clinical Microbiology and Infection 2002, 8:634-640.
26. Jankovic D., Kullberg M.C., Feng C.G., Goldszmid R.S., Collazo C.M., Wilson M., Wynn T.A., Kamanaka M., Flavell R.A., Sher A. Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. Journal of Experimental Medicine 2007, 204:273-283.
27. Johnson L.L. A protective role for endogenous tumor necrosis factor in Toxoplasma gondii infection. Infection and Immunity 1992, 60:1979-1985.
28. Kodjikian L., Hoigne I., Adam O., Jacquier P., Aebi-Ochsner C., Aebi C., Garweg J.G. Vertical transmission of toxoplasmosis from a chronically infected immunocompetent woman. Pediatric Infectious Disease Journal 2004, 23:272-274.
29. Leng J., Butcher B.A., Egan C.E., Abdallah D.S., Denkers E.Y. Toxoplasma gondii prevents chromatin remodeling initiated by TLR-triggered macrophage activation. Journal of Immunology 2009, 182:489-497.
30. Leyva R., Hérion P., Saavedra R. Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii. Parasitology Research 2001, 87:70-79.
31. Liu C.H., Fan Y.T., Dias A., Esper L., Corn R.A., Bafica A., Machado F.S., Aliberti J. Cutting edge: dendritic cells are essential for in vivo IL-12 production and development of resistance against Toxoplasma gondii infection in mice. Journal of Immunology 2006, 177:31-35.
32. Ma X., Chow J.M., Gri G., Carra G., Gerosa F., Wolf S.F., Dzialo R., Trinchieri G. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. Journal of Experimental Medicine 1996, 183:147-157.
33. Mattos C.C., Meira C.S., Ferreira A.I., Frederico F.B., Hiramoto R.M., Mattos G.C., Pereira-Chioccola L.C.V.L. Contribution of laboratory methods in diagnosing clinically suspected ocular toxoplasmosis in Brazilian patients. Diagnostic Microbiology and Infectious Disease 2011, 70:362-366.
34. Meira C.S., Costa-Silva T.A., Vidal J.E., Ferreira I.M., Hiramoto R.M., Pereira-Chioccola V.L. Use of the serum reactivity against Toxoplasma gondii excreted-secreted antigens in cerebral toxoplasmosis diagnosis in human immunodeficiency virus-infected patients. Journal of Medical Microbiology 2008, 57:845-850.
35. Meira C.S., Vidal J.E., Costa-Silva T.A., Frazatti-Gallina N., Pereira-Chioccola V.L. Immunodiagnosis in cerebrospinal fluid of cerebral toxoplasmosis and HIV-infected patients using Toxoplasma gondii excreted/secreted antigens. Diagnostic Microbiology and Infectious Disease 2011, 71:279-285.
36. Mesquita R.T., Ziegler A.P., Hiramoto R.M., Vidal J.E., Pereira-Chioccola V.L. Real-time quantitative PCR in cerebral toxoplasmosis diagnosis of Brazilian human immunodeficiency virus-infected patients. Journal of Medical Microbiology 2010, 59:641-647.
37. Noor S., Habashy A.S., Nance J.P., Clark R.T., Nemati K., Carson M.J., Wilson E.H. CCR7-dependent immunity during acute Toxoplasma gondii infection. Infection and Immunity 2010, 78:2257-2263.
38. O'Garra A., Vieira P. T(H)1 cells control themselves by producing interleukin-10. Nature Reviews Immunology 2007, 7:425-428.
39. Pereira-Chioccola V.L., Vidal J.E., Su C. Toxoplasma gondii infection and cerebral toxoplasmosis in HIV-infected patients. Future Microbiology 2009, 4:1363-1379.
40. Prigione I., Facchetti P., Lecordier L., Deslée D., Chiesa S., Cesbron-Delauw M.F., Pistoia V. T cell clones raised from chronically infected healthy humans by stimulation with Toxoplasma gondii excretory-secretory antigens cross-react with live tachyzoites: characterization of the fine antigenic specificity of the clones and implications for vaccine development. Journal of Immunology 2000, 164:3741-3748.
41. Reimão J.Q., Colombo F.A., Pereira-Chioccola V.L., Tempone A.G. In vitro and experimental therapeutic studies of the calcium channel blocker bepridil: detection of viable Leishmania (L.) chagasi by real-time PCR. Experimental Parasitology 2011, 128:111-115.
42. Rosenberg C., De Craeye S., Jongert E., Gargano N., Beghetto E., Del Porto P., Vorup-Jensen T., Petersen E. Induction of partial protection against infection with Toxoplasma gondii genotype II by DNA vaccination with recombinant chimeric tachyzoite antigens. Vaccine 2009, 27:2489-2498.
43. Scharton-Kersten T.M., Wynn T.A., Denkers E.Y., Bala S., Grunvald E., Hieny S., Gazzinelli R.T., Sher A. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. Journal of Immunology 1996, 157:4045-4054.
44. Silveira C., Ferreira R., Muccioli C., Nussenblatt R., Belfort R. Toxoplasmosis transmitted to a newborn from the mother infected 20 years earlier. American Journal of Ophthalmology 2003, 136:370-371.
45. Sun J., Madan R., Karp C.L., Braciale T.J. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nature Medicine 2009, 15:277-284.
46. Swain S.L., Weinberg A.D., English M., Huston G. IL-4 directs the development of Th2-like helper effectors. Journal of Immunology 1990, 145:3796-3806.
47. Vercammen M., Scorza T., Huygen K., De Braekeleer J., Diet R., Jacobs D., Saman E., Verschueren H. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infection and Immunity 2000, 68:38-45.
48. Vidal J.E., Hernandez A.V., de Oliveira A.C., Dauar R.F., Barbosa S.P., Focaccia R. Cerebral toxoplasmosis in HIV-positive patients in Brazil: clinical features and predictors of treatment response in the HAART era. Aids Patient Care and STDS 2005, 19:626-634.
49. Yap G., Pesin M., Sher A. IL-12 is required for the maintenance of IFN-gamma production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. Journal of Immunology 2000, 165:628-631.
50. Zenner L., Estaquier J., Darcy F., Maes P., Capron A., Cesbron-Delauw M.F. Protective immunity in the rat model of congenital toxoplasmosis and the potential of excreted-secreted antigens as vaccine components. Parasite Immunology 1999, 21:261-272.